1. Home
  2. ENTX vs GPRO Comparison

ENTX vs GPRO Comparison

Compare ENTX & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

N/A

Current Price

$3.14

Market Cap

147.4M

Sector

Health Care

ML Signal

N/A

Logo GoPro Inc.

GPRO

GoPro Inc.

N/A

Current Price

$0.64

Market Cap

166.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTX
GPRO
Founded
2010
2004
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
147.4M
166.3M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
ENTX
GPRO
Price
$3.14
$0.64
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $9.75
N/A
AVG Volume (30 Days)
390.9K
★ 6.1M
Earning Date
11-06-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 79.08
EPS
★ 0.33
N/A
Revenue
$42,000.00
★ $651,542,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$35.48
P/E Ratio
$9.68
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.91
$0.57
52 Week High
$4.20
$2.05

Technical Indicators

Market Signals
Indicator
ENTX
GPRO
Relative Strength Index (RSI) 55.16 20.51
Support Level $2.76 $0.58
Resistance Level $3.56 $0.65
Average True Range (ATR) 0.21 0.06
MACD 0.00 -0.03
Stochastic Oscillator 47.22 0.09

Price Performance

Historical Comparison
ENTX
GPRO

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

Share on Social Networks: